Follicular Lymphoma Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
T
Recruiting
  • Follicular Lymphoma
  • Small Lymphocytic Lymphoma
  • Fort Myers, Florida
  • +2 more
2022-01-12
Jan 12, 2022
T
Recruiting
  • CLL
  • +9 more
  • TG-1801
  • Ublituximab
  • Fayetteville, Arkansas
  • +4 more
2022-01-12
Jan 12, 2022
H
Recruiting
  • Chronic Lymphocytic Leukemia
  • Follicular Lymphoma
  • obinutuzumab
  • Busan, Korea, Republic of
  • +15 more
2022-01-12
Jan 12, 2022
T
Active, not recruiting
  • Diffuse Large B-Cell Lymphoma
  • +4 more
  • Ublituximab
  • +2 more
  • Birmingham, Alabama
  • +167 more
2022-01-12
Jan 12, 2022
N
Recruiting
  • Follicular Lymphoma
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-01-11
Jan 11, 2022
P
Active, not recruiting
  • Follicular Lymphoma
  • +2 more
  • Induction Venetoclax
  • Maintenance Venetoclax
  • Atlanta, Georgia
  • +9 more
2021-12-22
Dec 22, 2021
G
Active, not recruiting
  • Diffuse Large B Cell Lymphoma
  • +5 more
  • epcoritamab
  • Aichi, Japan
  • +19 more
2022-01-07
Jan 7, 2022
A
Recruiting
  • Diffuse Large B Cell Lymphoma
  • Follicular Lymphoma
  • Brisbane, Queensland, Australia
  • +2 more
2021-12-20
Dec 20, 2021
D
Not yet recruiting
  • Follicular Lymphoma
  • Boston, Massachusetts
    Dana Farber Cancer Institute
2022-01-10
Jan 10, 2022
T
Terminated
  • Diffuse Large B Cell Lymphoma
  • +3 more
  • LUCAR-20S CAR-T cells
  • Hefei, Anhui, China
  • +2 more
2021-12-17
Dec 17, 2021
H
Active, not recruiting
  • Follicular Lymphoma
  • Pescara, Abruzzo, Italy
  • +45 more
2022-01-06
Jan 6, 2022
P
Not yet recruiting
  • Lymphoma
  • +6 more
  • Digital Health Coaching
  • Houston, Texas
    The University of Texas MD Anderson Cancer Center
2022-01-05
Jan 5, 2022
U
Recruiting
  • Follicular Lymphoma
  • +2 more
  • Laboratory Biomarker Analysis
  • Pembrolizumab
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2021-12-15
Dec 15, 2021
H
Not yet recruiting
  • CLL/SLL
  • +8 more
  • (no location specified)
2021-12-14
Dec 14, 2021
J
Enrolling by invitation
  • Chronic Lymphocytic Leukemia
  • +6 more
  • Duarte, California
  • +165 more
2021-12-30
Dec 30, 2021
N
Recruiting
  • Follicular Lymphoma
  • +3 more
  • CD22-CAR
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
2021-12-29
Dec 29, 2021
G
Recruiting
  • Follicular Lymphoma
  • Long Beach, California
  • +106 more
2021-12-24
Dec 24, 2021
N
Recruiting
  • Follicular Lymphoma
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2021-12-21
Dec 21, 2021
U
Recruiting
  • Hematologic Diseases
  • +11 more
  • Ann Arbor, Michigan
    University of Michigan Health System
2021-12-02
Dec 2, 2021
N
Active, not recruiting
  • Follicular Lymphoma
  • tisagenlecleucel
  • Duarte, California
  • +29 more
2021-12-06
Dec 6, 2021
C
Recruiting
  • Follicular Lymphoma
  • Endometrial Cancer
  • New York, New York
  • +2 more
2021-11-24
Nov 24, 2021
T
Active, not recruiting
  • Follicular Lymphoma
  • +3 more
  • Angers, France
  • +24 more
2021-12-06
Dec 6, 2021